Analyst Alan Carr of Needham weighed in on Intercept Pharmaceuticals (NASDAQ:ICPT) and Cempra Inc (NASDAQ:CEMP) today. Intercept Pharmaceuticals Carr maintains a Buy rating on …
Intercept Pharmaceuticals Inc (NASDAQ:ICPT), a clinical stage biopharmaceutical company focused on the development and commercialization of novel therapeutics to treat chronic, underserved liver diseases, …
Intercept Pharmaceuticals Inc (NASDAQ:ICPT), a clinical stage biopharmaceutical company focused on the development and commercialization of novel therapeutics to treat chronic underserved liver diseases, …
The biotechnology sector is very fast-paced as every event, such as new data, FDA decisions, and trial initiations can double or deplete a …
Never a dull moment in the volatile biotechnology sector as analysts remain bullish on Intercept Pharmaceuticals Inc (NASDAQ:ICPT) as the company prepares to …
Analyst Liana Moussatos of Wedbush rates stocks in the biotechnology sector and is one of the top 100 analysts rated on TipRanks. Today, Moussatos provided commentary …
Analyst Alan Carr of Needham rates stocks in the biotechnology sector and is one of the top 25 analysts rated on TipRanks. Today, …
Cowen remains bullish on Intercept Pharmaceuticals Inc (NASDAQ:ICPT) as the company designs Phase 2 and 3 trials for its pipeline drug aimed to …
Analysts are weighing in on the Valencia biomedical company MannKind Corporation (NASDAQ:MNKD) and biopharmaceutical company Intercept Pharmaceuticals Inc (NASDAQ:ICPT), as both stocks are suffering losses on …
